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Abstract
Introduction & aim of work: Transcatheter treatment for critical pulmonary stenosis and membranous pulmonary atresia
has become the gold standard of care in many centers. We aimed at evaluating the predictors of outcome in interventions
for treatment of duct-dependent right ventricular outﬂow tract obstruction with intact interventricular septum.
Subjects & methods: 68 cases with pulmonary atresia with intact interventricular septum (PA/IVS) and 50 cases with
critical pulmonary stenosis (CPS), all younger than 3 months of age, were operated during the period of 10 years;
excluding patients with tricuspid valve annulus Z-score smaller than -4, evidence of right ventricular-dependent coronary circulation or additional malformations.
Results: Age, weight, body surface area as well as tricuspid & pulmonary valve Z-scores were signiﬁcantly less in PA/
IVS; right ventricular pressure was similar in both groups however procedural success and survival to hospital discharge
was higher in the CPS group. Lower age, weight and body surface area were associated with procedural failure. Weight
was the only predictor of procedural success; while weight and lower post-procedural right ventricular pressure were
independent predictors for survival to hospital discharge. Post-procedural right ventricular pressure and length of stay
were less in the CPS group. tricuspid and pulmonary valve annulus Z-scores were the only independent predictors of the
post-procedural milrinone duration in PA/IVS.
Conclusion: We advocate for the use of larger balloon/pulmonary annulus ratio, to achieve a lower right ventricular
pressure not fearing excessive pulmonary regurgitation that might be beneﬁcial for right ventricular growth; and for the
combination with ductal stenting in borderline or bipartite right ventricles.
Keywords: Critical pulmonary stenosis, Pulmonary atresia, Transcatheter intervention, Outcome

1. Introduction

N

eonates with critical pulmonary stenosis
(CPS) or complete pulmonary atresia (PA)
with intact interventricular septum (IVS) display a
wide range of hypoplasia affecting the different
right ventricular (RV) components [1]. These are
rare cyanotic congenital heart defects (CHD)
constituting about 3% of all CHD [2,3].
Currently, percutaneous balloon pulmonary valvuloplasty (PBPV) with or without perforation of the
atretic valve has proven effective and could be
applied as the principal treatment with few

complications [4]. However, selective and stratiﬁed
methods have become more sophisticated in the last
2 decades greatly contributing to improvement in
the clinical outcome [5e7]. Strictly following the
management algorithms is proposed to achieve best
outcomes [7].
The pediatric cardiac intensivist is faced with a
challenging spectrum of post-interventional pathophysiological statuses [1]. However, given the rarity
of this CHD, there is paucity of data regarding
clinical outcomes [8]. This study aimed at evaluating
the predictors of procedural success, survival and
length of ICU stay following primary catheter
intervention in neonates with PA/IVS and CPS/IVS.
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2. Patients and methods
This is a retrospective study that included all patients with right ventricular outﬂow tract obstruction
(RVOTO), IVS and no major sinusoidal communications that received transcatheter treatment at
Cairo University Children's Hospital during the
period from October 2009 to August 2019. A total of
118 patients were included in the study: of these 68
patients had PA/IVS (group 1); and 50 patients had
CPS/IVS (group 2). All procedures were performed
by the same team of operators. Patients with additional malformations were excluded. Tricuspid valve
variables such as Ebstein's anomaly or various hypoplasia/dysplasia were included, however, a
tricuspid valve (TV) annulus Z-score smaller than 3
were referred from the start for patent ductus arteriosus (PDA) stenting or a modiﬁed Blalock-Taussig
(MBT) shunt.
This study was approved by the Cairo University
ethical committee.
2.1. Patient preparation
Clinical data obtained included age, weight and
length at intervention; and baseline oxygen saturation. Electrocardiograms and chest radiograms were
performed for all cases. Anatomical details by
echocardiography were obtained using a Vivid 5
machine and a 5 MHz phased array probe (GE,
Vingmed Ultrasound AS, Horten, Norway). Echocardiographic assessment protocol included the TV
and mitral valve (MV) annuli from the apical 4
chamber view; the pulmonary valve (PV) annulus
and main pulmonary artery (MPA) from the parasternal short axis view; PDA morphology and size in
the parasternal ductal view; and the size of the
interatrial communication from the subcostal view.
Z-scores were calculated from the algorithms published by the Daubeney group [9]. Informed consents for the required intervention and for utilizing
data in research were obtained from the parents
prior to interventions, whether radiofrequency
perforation of the PV and valvuloplasty for PA/IVS,
or PBPV for CPS/IVS.
Neonates with CPS were patients presenting with
cyanosis related to right-left shunting across the patent foramen oval (PFO) and duct-dependent pulmonary circulation; PA was considered when there was
complete membranous atresia of the PV with an
adequate-sized MPA. Neonates were nominated
suitable for transcatheter approach if the RV was
tripartite or bipartite; with a TV annulus Z score 3 or
larger; and showing no right ventricular-dependent
coronary circulation (RVDCC). All our included
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patients were diagnosed in the neonatal period,
however, some of the cases (14) were operated later on
in life being referred from remote areas and presenting to our center later than the neonatal period.
2.2. Catheterization procedure
Procedures were performed under general anesthesia; patients were monitored throughout the
procedure by an anesthesiologist. After obtaining
vascular accesses, a 4 or 5-F multipurpose (MPA 1)
catheter (Cordis, Miami, FL, USA) was used to
measure RV pressure (RVP) and perform a diagnostic right ventriculogram in the lateral and frontal
projections to assess the RV morphology, rule-out
coronary sinusoids and measure the PV annulus. In
cases of PA/IVS, a 4-F pigtail catheter (Cordis,
Miami, FL, USA) was used to measure aortic pressure (AoP). An aortogram was performed to deﬁne
PDA morphology, size, and coronary anatomy. The
MPA was then approached retrogradely via the PDA
using a cut pigtail catheter and a snare was placed.
In both conditions, a 4- or 5-F Judkins right catheter with 1.5, 2 or 3.5 curve (Cordis, Miami, FL, USA)
was maneuvered into the infundibulum with a Yconnector (Cook, Bloomington, IN), allowing intermittent contrast injections to deﬁne the valve plane.
In cases with PA/IVS the PV was perforated after
good positioning by a radiofrequency wire ((Nykanen RF wire, Baylis Medical, Montr
eal, Canada) or
the stiff end of a coronary wire (Boston scientiﬁc,
this was used in a few cases at the start of our

experience), followed by snaring of the wire and
forming an arterio-venous loop. Alternatively, a
coronary wire was passed adjacent to the Nykanen
wire to track it to a pulmonary artery branch or the
descending Aorta. Hybrid procedure was attempted
in only 2 cases were peripheral vascular access
failed in the ﬁrst, and proper positioning of the radio
frequency (RF) wire was difﬁcult in the latter. The
tiny opening of the PV was subsequently crossed by
a coronary or Terumo wire, balloon dilatation was
then performed using a Tyshak II or Tyshak MINI
balloon, of size around 120% of the PV annulus. Predilatation using a coronary balloon was attempted
in most cases. In a few (3) cases, PDA stenting was
performed following pulmonary valvuloplasty
based on small RV volume and the expectation of a
restrictive RV physiology.
Following successful interventions, post-intervention care of patients with PA/IVS at the pediatric
cardiac intensive care unit (PCICU) included
continuation of prostaglandin E1 (PGE1) and milrinone infusions until the RV was rehabilitated, evidenced by stabilization of oxygen saturation above
70% and left-to-right shunting across the PFO.
Furosemide doses were frequently administered
upon evidence of pulmonary and/or systemic
congestion. Propranolol was given whenever
hyperdynamic RVOTO was seen on echocardiography. Post- intervention care for babies with CPS
seldom required PGE1 infusion for a short period to
support pulmonary circulation until saturations stabilized. The patients were maintained also on both
propranolol and angiotensin converting enzyme inhibitor (captopril) [10].
A successful procedure was deﬁned as procedures
where the RVP was reduced to less than half the
pre-procedural pressure, and the patients were
discharged to the PCICU in a stable condition.
Otherwise, the procedure was deﬁned as a failure.
2.3. Statistical methods
Data were analyzed using IBM© SPSS© Statistics
version 23 (IBM© Corp., Armonk, NY). Continuous

numerical variables were presented as mean and
SD and inter-group differences were compared
using the unpaired t-test. Categorical variables were
presented as number and percentage or ratio, and
differences were compared using the Pearson chisquared test. Correlations between numerical variables were tested using the Pearson correlation.
Multivariable binary logistic regression analysis
(after adjustment for the effect of included variables)
was used to examine the predictors of success of the
procedure. To examine the predictors of post-procedure RVP, multivariable linear regression was
used; while Cox proportional hazard regression was
used to identify predictors of survival to hospital
discharge (after adjustment of other cofounders in
both methods). Two-tailed p-values <0.05 were
considered statistically signiﬁcant.

3. Results
A total of 118 patients were performed during the
study period. This included 68 PA/IVS and 50 CPS
patients. All patients included were below three
months of age. Table 1 shows the anthropometric
and pre-procedural data. The age, weight, height
and BSA of PA/IVS cases were signiﬁcantly less
than those with CPS [p < 0.001, 0.001, 0.002, and
<0.001 respectively].
By comparing pre-procedural echocardiographic
parameters (Table 2): TV annulus, TV z-scores and
PV z-scores were signiﬁcantly lower in the PA/IVS
cases ( p ¼ 0.018, <0.001, and <0.001 respectively).
On comparing procedural and post-procedural
data, radiation time was signiﬁcantly lower in the
CPS group ( p < 0.001). Pre-intervention RVP was
similar in both groups (Table 3).
Procedural success was higher in the CPS than the
PA/IVS group (86% compared to 73.5%): were 8 out
of 50 cases with CPS failed versus 18 out of 68 in the
PA/IVS group, mainly due to failure to achieve a
suitable subpulmonic RVOT position. Similarly,
survival to hospital discharge was higher in cases
with CPS (97%) compared to 54% in the PA/IVS
group (Table 4). Mortality in the CPS group was
mostly due to postprocedural sepsis; also in the PA/

Table 1. Comparison of patients with PA/IVS and CPS.
Variable

Age (days)
Weight (kg)
Height (cm)
BSA (m2)

PA/IVS group
(n ¼ 68)

CPS group
(n ¼ 50)

Mean
Difference

Mean

SD

Mean

SD

22.1
3.12
50.5
0.20

18.8
0.56
3.3
0.02

46.3
3.78
53.2
0.23

30.6
1.29
5.1
0.05

24.2
0.7
2.7
0.03

Data expressed as mean and standard deviation (SD); 95% CI, 95% conﬁdence interval.
*Independent samples t-test.

95% CI

P-value*

Lower

Upper

33.9
1.1
4.3
0.04

14.4
0.3
1.0
0.01

<0.001
0.001
0.002
<0.001
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Table 2. Comparison of pre-procedural data.
Variable

Duration of pre-procedure
alprostadil (days)
PDA diameter (mm)
PFO diameter (mm)
MV annulus (mm)
MV annulus Z-score
TV annulus (mm)
TV annulus Z-score
PV annulus (mm)
PV annulus Z-score

PA/IVS group
(n ¼ 68)

CPS group
(n ¼ 50)

Mean
Difference

Mean

SD

Mean

SD

8.0

8.1

3.2
4.9
13.0
1.710
13.7
0.99
7.7
0.17

0.8
1.7
2.1
1.180
3.7
1.44
1.4
1.27

12.5
0.07
7.3
1.35

1.5
0.76
1.0
0.67

95% CI

1.2
0.92
0.4
1.18

P-value*

Lower

Upper

0.2
0.52
0.0
0.82

2.2
1.33
0.8
1.54

0.018
<0.001
0.070
<0.001

*Independent samples t-test.
Table 3. Comparison of procedural and post-procedural data.
Variable

PA/IVS group
(n ¼ 68)

CPS group
(n ¼ 50)

Mean
Difference

95% CI

P-value*

Mean

SD

Mean

SD

Lower

Upper

RVP (mmHg)
AoP (mmHg)
Irradiation time (s)
Irradiation dose (Gy/m2)
Duration of post-procedure
PGE1 (days)
Duration of post-procedure
milrinone (days)

116.7
68.2
2968.0
34.3
5.7

26.5
11.4
1343.0
54.3
4.2

111.8

33.0

4.9

6.0

15.8

0.373

1515.0
24.4

1128.0
20.8

1453.2
9.9

989.5
6.1

1916.8
26.0

<0.001
0.221

3.4

3.6

*Independent samples t-test.
Table 4. Main outcome measures in patients with PA/IVS and CPS.
Variable

Procedural success
Survival to hospital discharge

Failed
Successful
Survived
Died

PA/IVS group
(n ¼ 68)

CPS group
(n ¼ 50)

N

%

N

%

18
50
38
30

26.5%
73.5%
55.9%
44.1%

7
43
48
2

14.0%
86.0%
96.0%
4.0%

c2 (df)

P-value*

2.684 (1)

0.101

23.463 (1)

<0.001

Data are number (n) and percentage (%).
c2 ¼ chi-squared statistic, df ¼ degree of freedom.
*Pearson chi-squared test.

IVS causes were mainly related to sepsis in addition
to cardiac tamponade and metabolic disturbances in
a minority (Fig. 1).

On comparing the patients receiving a successful
procedure with those who failed (Table 5), we found
that lower age, weight and body surface area (BSA)

Fig. 1. Flowchart of the study cases a) CPS; and b) PA/IVS.

Table 5. Comparison of patients with failed or successful procedure.
Variable

Age (days)
Weight (kg)
Height (cm)
BSA (m2)
Duration of pre-procedure
PGE1 (days)
PDA diameter (mm)
PFO diameter (mm)
MV annulus (mm)
MV annulus Z-score
TV annulus (mm)
TV annulus Z-score
PV annulus (mm)
PV annulus Z-score
Pre-procedure RVP (mmHg)
AoP (mmHg)
Operative technique (RF/CSP)

Failed
procedure
(n ¼ 25)

Successful
procedure
(n ¼ 93)

Mean
Difference

95% CI
Lower

Upper

P-value*

23.6 ± 22.6
3.0 ± 0.7
51.5 ± 3.4
0.203 ± 0.027
9.3 ± 7.8

34.7 ± 27.9
3.5 ± 1.0
51.7 ± 4.6
0.218 ± 0.041
7.6 ± 8.2

11.1
0.5
0.2
0.015
1.7

22.0
0.9
2.2
0.029
2.8

0.3
0.0
1.7
0.001
6.2

0.044
0.038
0.808
0.034
0.450

2.9 ± 0.7
4.9 ± 1.7
13.8 ± 2.5
2.08 ± 1.38
13.9 ± 3.9
0.89 ± 1.51
7.3 ± 1.5
0.64 ± 1.33
118.6 ± 28.2
66.7 ± 7.9
18/7

3.3 ± 0.9
4.9 ± 1.7
12.7 ± 1.9
1.58 ± 1.08
13.0 ± 2.8
0.52 ± 1.21
7.6 ± 1.2
0.68 ± 1.17
113.5 ± 29.8
68.8 ± 12.5
50/43

0.4
0.0
1.0
0.50
0.8
0.37
0.4
0.05
5.1
2.1
e

0.9
1.0
0.1
0.14
0.5
0.20
0.9
0.49
8.1
8.4
e

0.04
0.9
2.2
1.14
2.2
0.94
0.2
0.59
18.3
4.2
e

0.076
0.973
0.076
0.124
0.230
0.200
0.218
0.865
0.445
0.502
0.101x

Data are mean ± standard deviation (SD) or ratio.
95% CI, 95% conﬁdence interval.
*Independent samples t-test unless otherwise indicated.
x
Pearson chi-squared test.

were associated with procedural failure ( p-values of
0.044, 0.038 and 0.034, respectively) (Fig. 2). No association was found with pre-procedural echocardiographic parameters, duration of PGE1 duration,
pre-intervention RVP or AoP, or operative technique.
Predictors of procedural success were observed by
multivariable binary logistic regression analysis
(Suppl. Table 1): no statistically signiﬁcant relation
with the interventional technique, i.e., initial diagnosis ( p ¼ 0.272), age ( p ¼ 0.697), weight ( p ¼ 0.154),
pre-procedure RVP ( p ¼ 0.435), TV annulus Z-score
( p ¼ 0.634) or PV annulus Z-score ( p ¼ 0.354). Using
multivariable backward binary logistic regression,
weight was the only variable retained in the model

Fig. 2. Mean a) age; b) weight; and c) BSA in patients with failed or
successful procedure. Error bars represent the standard error (SE).

with a statistically signiﬁcant relation to success of
the procedure (OR ¼ 1.824, 95% CI ¼ 1.022 to 3.254,
p ¼ 0.042). Each 1 kg increase in the baby's weight
was associated with an increase of 0.824 in the odds
of success (Suppl. Table 2). Although weight is
linked with diagnosis, as patients with PA/IVS tend
to present earlier, however, age did not have a
similar impact on outcome.
On studying predictors of survival to hospital
discharge using Cox- proportional hazard regression (Suppl. Table 3): weight (Cox proportional
hazard ¼ 0.545, 95% CI ¼ 0.302 to 0.983, p ¼ 0.044)
and post-procedure RVP (Cox proportional
hazard ¼ 1.023, 95% CI ¼ 1.010 to 1.037, p ¼ 0.001)
were independent predictors of survival to hospital
discharge. There was no statistically signiﬁcant
relation between survival and the interventional
technique ( p ¼ 0.312) or age ( p ¼ 0.865) (Fig. 3).
The secondary outcome measures that were
studied in both groups included post-procedure
RVP and ICU length of stay (LOS), and both were
signiﬁcantly lower in CPS group [p < 0.001 for both]
(Table 6, Fig. 4).
The interventional procedure was the only independent predictor of post-procedure RVP
(B ¼ 15.224, SE ¼ 4.911, p ¼ 0.002) where CPS was
associated with a lower RVP of about 15 mmHg
compared with PA/IVS (Suppl. Table 4). On correlating the post-procedure RVP with all variables
(Suppl. Table 5), a weak positive correlation was
found with the pre-intervention AoP ( p ¼ 0.037) and
post-procedure PGE1 ( p ¼ 0.044) (Fig. 5).
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SE ¼ 0.330, p ¼ 0.008) were the only independent
predictors of the post-procedural milrinone duration in patients with PA/IVS (Suppl. Table 7), while
lower TV Z-score and higher PV Z-scores were
associated with longer duration of post-procedure
milrinone. However, no independent predictor of
the post- procedural PGE1 duration was found (all
p-values >0.05).

4. Discussion

Fig. 3. Cox proportional hazard survival curves for patients with PA/IVS
and CPS.

Studying correlations between different parameters and need to post-intervention drugs in patients
with PA/IVS (Suppl. Table 6) showed that RVP was
directly proportionate with the need for PGE1 infusion; while the period on milrinone was inversely
proportionate to the MV and TV valve annuli, but
was directly proportionate to the PV annulus (Fig. 6).
The TV annulus Z-score (B ¼ 0.695, SE ¼ 0.302,
p ¼ 0.025) and PV annulus Z-score (B ¼ 0.908,

Percutaneous balloon valvuloplasty of the pulmonary valve was ﬁrst described by Kan et al., in
1982 [11]. A decade later another remarkable
advance in transcatheter intervention was RF
perforation for PA/IVS introduced by Qureshi et al.,
in 1991 [12], this led to signiﬁcant improvement of
outcomes in these lesions, and it has been adopted
by the majority of cardiac centers as a gold standard
procedure in appropriately-selected patients [4,5].
Interventional therapy for PA/IVS during the
neonatal period was reported to have a high success
rate, with a mid-and long-term survival rate ranging
from 81.0 to 92.5% [6,7,13].
We aim whenever possible for biventricular repair
due to better long-term outcome than univentricular
repair; however, proper selection of borderline
cases is extremely important to avoid intervening in

Table 6. Secondary outcome measures in patients with PA/IVS and CPS.
Variable

Post-procedure RVP (mmHg)
ICU LOS (days)

PA/IVS group
(n ¼ 68)

CPS group
(n ¼ 50)

Mean
Difference

Mean

SD

Mean

SD

56.8
8.1

25.5
4.8

42.5
3.4

8.7
1.8

14.3
4.7

95% CI

P-value*

Lower

Upper

7.7
3.4

20.9
5.9

<0.001
<0.001

Data are mean and standard deviation (SD).
95% CI, 95% conﬁdence interval.
*Independent samples t-test.

Fig. 4. a) Mean post-procedure RVP in patients PA/IVS and CPS; and b) mean ICU LOS in patients with PA/IVS and CPS. Error bars represent the
standard error (SE).
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Fig. 5. Scatter plots illustrating a) the correlation between pre-procedure AoP and post-procedure RVP: there is weak negative correlation between both
variables (r ¼ 0.254, p ¼ 0.037, R2 ¼ 0.064); and b) the correlation between the duration of post-procedure PGE1 and post-procedure RVP: there is
weak positive correlation between both variables (r ¼ 0.245, p ¼ 0.044, R2 ¼ 0.060).

Fig. 6. Scatter plot illustrating a) the correlation between the duration of post-procedure milrinone and MV annulus Z-score: there is weak negative
correlation between both variables (r ¼ 0.242, p ¼ 0.047, R2 ¼ 0.058); b) the correlation between the duration of post-procedure milrinone and TV
annulus Z-score: there is weak negative correlation between both variables (r ¼ 0.262, p ¼ 0.031, R2 ¼ 0.069); and c) the correlation between the
duration of post-procedure milrinone and PV annulus Z-score: there is weak positive correlation between both variables (r ¼ 0.245, p ¼ 0.044,
R2 ¼ 0.060).

cases that will fail biventricular repair [14,15].
Restoration of RV to pulmonary artery continuity
(RACHS-1 category 2) [16] is an absolute requirement for growth of the hypoplastic RV. In its
absence, the dimensions of the RV and the TV
actually decrease as the patient grows [17,18]. Even
the systemic-to-pulmonary arterial shunt does not
inﬂuence RV growth [19].
To the best of our knowledge, this study is
reporting the largest number of patients who underwent interventional cardiac catheterization for
CPS or PA/IVS mostly in the neonatal period. The
study included patients considered suitable to achieve biventricular repair with either tripartite or
bipartite RV with no RVDCC. In some cases ductal
stenting was done in patients where a complementary source of pulmonary ﬂow was expected like
bipartite RV with small PV and TV.
In our study, procedural success was related to
age, weight and BSA rather than the interventional
technique (i.e., initial diagnosis). These parameters
were lower in the PA/IVS group which explains the
discrepancy in procedural outcomes between the
two groups. Weight was the only predictor for

success of the procedure. Similarly, multiple reports
are available on the association of weight and
gestational age with procedural outcome [20].
Survival was similarly associated with weight, and
also to post-intervention RVP. Given that preintervention RVP was similar in both groups unlike
the post-intervention RVP that was signiﬁcantly less
by around 15 mmHg in the CPS group, the need for
achieving a lower post-RVP by repeat dilatations or
balloon over-sizing is reasoned: it was documented
that the rate of reintervention is associated with
higher post-RVP and residual pulmonary valve
pressure gradient rather than the PV annulus or
balloon/annulus ratio [21].
Whether the pulmonary annulus is underestimated in the setting of complete atresia versus the
need to use a larger balloon/annulus ratio than
traditionally selected was always checked by the fear
of development of signiﬁcant PR, however, it might
be argued that such a volume load to the RV might be
advantageous on the long-term by promoting RV
growth, analogous to what was described in a large
multicenter cohort for the strong association of
tricuspid regurge severity with tricuspid valve
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annular dimension and tricuspid inﬂow duration,
suggesting that the regurgitant physiology affects
right ventricular development [22].
It is known that critical stenosis and complete
atresia of the pulmonary valve represent a spectrum
of the same disease that share similar physiology and
outcome. Our study supports that understanding as
we show that the type of procedure was not associated with procedural success or outcome, but rather
the post-operative RVP. Hence we can postulate that
conclusions could be applied to both groups [23].
All our patients with PA/IVS and selected cases
with CPS were infused with milrinone post-intervention to overcome RV stiffness until rehabilitation
of the RV stiffness occurs evidenced by the shift of
shunting across the PFO from RT-LT to LT-RT and
the rise of arterial saturations. As expected, smaller
TV z-score- that reﬂects RV hypoplasia [24] predicted a longer duration on milrinone infusion postintervention. Nevertheless, whilst this adaptation
takes time especially with the smaller, more
restrictive RVs [25], it exposes the patients to higher
risk of ICU-related complications. We came to
accept a bidirectional shunt and lower discharge
saturations to minimize hospital stay.
Post-procedure RVP had some correlation with a
longer post-procedural need for PGE1 infusion
which also reﬂects the RV stiffness and inadequacy
of forward pulmonary ﬂow. This advocates for the
need to combine RV decompression with ductal
stenting in borderline or bipartite RVs, to provide
adequate pulmonary ﬂow and maintain oxygen
saturations until rehabilitation of RV takes place
over time. A report by Chubb et al. on the long-term
outcome for patients with PA/IVS over a 19 year
period involving 39 cases reports a less hospital stay
for patients receiving PDA stenting in addition to
pulmonary valvotomy [26]. Another report by
Shwartz et al. including 23 cases over 11 years
concluded that a smaller TV z-score predicted the
need for supplementary blood ﬂow [27].
We have adopted the practice of combining RV
decompression with ductal stenting in the latter
years of our experience, whenever the team predicted a longer time for RV rehabilitation. Although
we seldomly intervened on cases with a TV z-score
smaller than 4, where patients were routed to the
univentricular pathway from the beginning by
ductal stenting or MBTS: based on the theory that

such RVs will not tolerate biventricular circulation
[26,28].
Conversely, higher PV z-scores predicted longer
duration on milrinone. Thus, it is postulated that the
PV annulus is not related to the RV stiffness and
hence, RV volume. Literature have described the
correlation between a smaller PA annulus with the
rates of re-stenosis [29], and reintervention [30]. Yet,
little is known on the relationship between the PA
annulus and the RV size or physiology. Nonetheless,
dilating the pulmonary valve is known to promote
catch-up growth of the pulmonary annulus [31,32],
another advocate for the use of a larger balloon/
annulus ratio.

5. Conclusion
In interventions for severe RVOTO, weight is the
predictor for procedural success, while survival to
hospital discharge is predicted by weight and lower
post-procedural RVP: which explains the fewer rates
in PA/IVS in both outcomes. The use of large balloon/
annulus ratio, and the combination with ductal stenting in PA/IVS with borderline or bipartite RVs might
prove beneﬁt in procedural success and outcome.
Further studies are needed to conﬁrm these ﬁndings
by including trans-valvular gradients for the complete
assessment of RVp, and the comparison for the effect
of combining PDA stenting on outcomes.
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Appendix A
Supplementary Table 1. Multivariable binary logistic regression analysis for predictors of success of the procedure.
Variable

B

SE

Wald

p-value

Odds ratio

95% CI

CPS (¼1)*
Age (days)
Weight (kg)
Pre-procedure RVP (mmHg)
TV annulus Z-score
PV annulus Z-score
Constant

0.659
0.005
0.533
0.006
0.094
0.208
0.170

0.600
0.012
0.374
0.008
0.197
0.224
1.357

1.208
0.152
2.030
0.610
0.226
0.861
0.016

0.272
0.697
0.154
0.435
0.634
0.354
0.900

1.933
1.005
1.703
0.994
0.911
1.231

0.597
0.981
0.819
0.978
0.619
0.793

to
to
to
to
to
to

6.259
1.030
3.544
1.010
1.339
1.911

B ¼ regression coefﬁcient, SE ¼ standard error, Wald ¼ Wald chi-squared statistic, 95% CI ¼ 95% conﬁdence interval.
*Referenced to RF (¼0).
Supplementary Table 2. Multivariable backward binary logistic regression analysis for predictors of success of the procedure.
Variable

B

SE

Wald

P-value

Odds ratio

95% CI

Weight (kg)
Constant

0.601
0.636

0.295
0.947

4.137
0.451

0.042
0.502

1.824

1.022 to 3.254

B ¼ regression coefﬁcient, SE ¼ standard error, Wald ¼ Wald chi-squared statistic, 95% CI ¼ 95% conﬁdence interval.
*Referenced to RF (¼0).
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 3. Cox proportional hazard regression for predictors of survival to hospital discharge.
Covariate

B

SE

Wald

P-value

Exp(b)

95% CI of Exp(b)

CPS (¼1)*
Age (days)
Weight (kg)
Post-procedure RVP (mmHg)

0.789
0.002
0.607
0.023

0.780
0.010
0.301
0.007

1.023
0.029
4.064
11.291

0.312
0.865
0.044
0.001

0.455
0.998
0.545
1.023

0.099
0.978
0.302
1.010

to
to
to
to

2.096
1.019
0.983
1.037

b ¼ regression coefﬁcient, SE ¼ standard error, Exp(b) ¼ Cox proportional hazard, 95% CI of Exp(b) ¼ 95% conﬁdence interval of Cox
proportional hazard.
*Referenced to PA/IVS (¼0).
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 4. Multivariable regression analysis for predictors of post-procedure RVP.
Independent variables

B

SE

T

P-value

(Constant)
CPS (¼1)*
Age (days)
Weight (kg)
TV annulus Z-score
PV annulus Z-score

62.732
15.224
0.003
1.627
1.053
0.792

4.911
0.095
2.513
1.659
1.860

3.100
0.029
0.648
0.635
0.426

0.002
0.977
0.519
0.527
0.671

B ¼ regression coefﬁcient, SE ¼ standard error, t ¼ t- statistic.
*Referenced to RF (¼0).
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 5. Correlation between post-procedure RVP and other quantitative variables.
Variable

Age
Weight
Height
BSA
Duration of pre-procedure PGE1
PDA diameter
PFO diameter
MV annulus
MV annulus Z-score
TV annulus
TV annulus Z-score
PV annulus
PV annulus Z-score

Post-procedure RVP
Pearson r

p-value

0.181
0.163
0.021
0.151
0.062
0.047
0.012
0.161
0.029
0.137
0.070
0.085
0.121

0.050
0.078
0.823
0.102
0.618
0.705
0.919
0.191
0.811
0.138
0.449
0.359
0.191
(continued on next page)

50

JOURNAL OF THE SAUDI HEART ASSOCIATION 2022;34:41e52

ORIGINAL ARTICLE

Supplementary Table 5. (continued )
Variable

Post-procedure RVP

TV annulus/MV annulus
Pre-procedure RVP
Pre-procedure AoP
Irradiation time
Irradiation dose
Duration of post-procedure PGE1
Duration of post-procedure milrinone
ICU LOS

Pearson r

p-value

0.001
0.058
¡0.254*
0.181
0.024
0.245*
0.096
0.156

0.995
0.532
0.037
0.050
0.796
0.044
0.437
0.095

*Correlation is signiﬁcant at the 0.05 level (2-tailed).
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 6. Correlation of the duration of post-procedure PGE1 or milrinone with other numerical variables in patients with PA/IVS.
Variable

Age
Weight
Height
BSA
Duration of pre-procedure PGE1
PDA diameter
PFO diameter
MV annulus
MV annulus Z-score
TV annulus
TV annulus Z-score
PV annulus
PV annulus Z-score
TV annulus/MV annulus ratio
Pre-procedure RVP
Pre-procedure AoP
Irradiation time
Irradiation dose
Post-procedure RVP

Duration of post-procedure
alprostadil

Duration of post-procedure
milrinone

Pearson r

P-value

Pearson r

P-value

0.010
0.042
0.008
0.032
0.067
0.080
0.204
0.106
0.161
¡0.276*
0.165
0.181
0.144
0.187
0.038
0.063
0.111
0.013
0.245*

0.935
0.732
0.949
0.797
0.590
0.517
0.095
0.390
0.190
0.023
0.180
0.140
0.240
0.127
0.756
0.610
0.369
0.919
0.044

0.089
0.012
0.158
0.101
0.138
0.166
0.145
0.196
¡0.242*
¡0.268*
¡0.262*
0.020
0.245*
0.125
0.045
0.017
0.139
0.051
0.096

0.470
0.923
0.198
0.412
0.261
0.176
0.238
0.108
0.047
0.027
0.031
0.872
0.044
0.311
0.714
0.893
0.257
0.682
0.437

*Correlation is signiﬁcant at the 0.05 level (2-tailed).
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 7. Multivariable regression analysis for predictors of the duration post- procedure milrinone in patients with PA/IVS.
Independent variables

B

SE

t

P-value

(Constant)
Age (days)
Weight (kg)
MV annulus Z-score
TV annulus Z-score
PV annulus Z-score
Post-procedure RVP (mmHg)

5.860
0.027
0.196
0.592
0.695
0.908
0.011

0.022
0.758
0.370
0.302
0.330
0.016

1.226
0.258
1.599
2.299
2.751
0.670

0.225
0.797
0.115
0.025
0.008
0.505

B ¼ regression coefﬁcient, SE ¼ standard error, t ¼ t- statistic.
Bold þ statistically-signiﬁcant outcomes.
Supplementary Table 8. Multivariable regression analysis for predictors of the duration post-procedure PGE1 in patients with PA/IVS.
Independent variables

B

SE

t

P-value

(Constant)
Age (days)
Weight (kg)
MV annulus Z-score
TV annulus Z-score
PV annulus Z-score
Post-procedure RVP (mmHg)

4.358
0.011
0.208
0.405
0.464
0.653
0.039

0.028
0.949
0.464
0.379
0.413
0.020

0.391
0.219
0.874
1.225
1.580
1.958

0.697
0.828
0.386
0.225
0.119
0.055

B ¼ regression coefﬁcient, SE ¼ standard error, t ¼ t- statistic.
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